Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7711287rdf:typepubmed:Citationlld:pubmed
pubmed-article:7711287lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7711287lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:7711287lifeskim:mentionsumls-concept:C1414387lld:lifeskim
pubmed-article:7711287pubmed:issue6lld:pubmed
pubmed-article:7711287pubmed:dateCreated1995-5-12lld:pubmed
pubmed-article:7711287pubmed:abstractTextA number of serine/threonine kinase receptors have recently been identified. Most of the members of this family are type I or type II receptors for proteins in the transforming growth factor-beta (TGF-beta) superfamily. The type I and type II receptors form heteromeric receptor complexes after binding of the ligands, and transduce intracellular signals. TGF-beta type I receptor needs type II receptor for ligand binding, and type II receptor needs type I receptor for signalling. The signal transducing molecules that interact with heteromeric serine/threonine kinase receptor complexes remain to be elucidated; cyclin-dependent kinases and the retinoblastoma protein appear to be downstream elements in the antiproliferative pathway of TGF-beta.lld:pubmed
pubmed-article:7711287pubmed:languageenglld:pubmed
pubmed-article:7711287pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711287pubmed:citationSubsetIMlld:pubmed
pubmed-article:7711287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711287pubmed:statusMEDLINElld:pubmed
pubmed-article:7711287pubmed:monthDeclld:pubmed
pubmed-article:7711287pubmed:issn1043-4682lld:pubmed
pubmed-article:7711287pubmed:authorpubmed-author:YamashitaHHlld:pubmed
pubmed-article:7711287pubmed:authorpubmed-author:HeldinC HCHlld:pubmed
pubmed-article:7711287pubmed:authorpubmed-author:MiyazonoKKlld:pubmed
pubmed-article:7711287pubmed:authorpubmed-author:ten DijkePPlld:pubmed
pubmed-article:7711287pubmed:issnTypePrintlld:pubmed
pubmed-article:7711287pubmed:volume5lld:pubmed
pubmed-article:7711287pubmed:ownerNLMlld:pubmed
pubmed-article:7711287pubmed:authorsCompleteYlld:pubmed
pubmed-article:7711287pubmed:pagination389-98lld:pubmed
pubmed-article:7711287pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7711287pubmed:meshHeadingpubmed-meshheading:7711287-...lld:pubmed
pubmed-article:7711287pubmed:meshHeadingpubmed-meshheading:7711287-...lld:pubmed
pubmed-article:7711287pubmed:meshHeadingpubmed-meshheading:7711287-...lld:pubmed
pubmed-article:7711287pubmed:meshHeadingpubmed-meshheading:7711287-...lld:pubmed
pubmed-article:7711287pubmed:meshHeadingpubmed-meshheading:7711287-...lld:pubmed
pubmed-article:7711287pubmed:year1994lld:pubmed
pubmed-article:7711287pubmed:articleTitleSignal transduction via serine/threonine kinase receptors.lld:pubmed
pubmed-article:7711287pubmed:affiliationLudwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.lld:pubmed
pubmed-article:7711287pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7711287pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7711287lld:pubmed